Literature DB >> 8644706

Discordant phenotype in siblings with X-linked agammaglobulinemia.

M J Bykowsky1, R N Haire, Y Ohta, H Tang, S S Sung, E S Veksler, J M Greene, S M Fu, G W Litman, K E Sullivan.   

Abstract

X-linked agammaglobulinemia (XLA) is a congenital humoral immunodeficiency caused by a defect in a B-cell-specific signaling molecule, Btk. There has been little concordance of phenotype with genotype in this disorder, and defects in Btk cause immunodeficiencies that range from mild impairment to complete inability to produce antibodies. The factors modifying the phenotype of XLA are not understood. The current study is the first description of two male siblings with identical T134 --> C mutations in the translation initiation ATG of Btk who have different clinical phenotypes. The proband lacks immunoglobulins and B cells and has recurrent infections, while the elder, affected brother has normal levels of IgG and IgM and very few infections. Both have undetectable levels of Btk kinase activity in circulating mononuclear cells. Complete sequencing of Btk gene transcripts in both brothers revealed no additional mutations to account for the discordant phenotypes. This description provides unequivocal evidence that the phenotype of XLA is influenced by factors additional to the Btk gene.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8644706      PMCID: PMC1914566     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  37 in total

Review 1.  Regulation of lymphocyte function by protein phosphorylation.

Authors:  R M Perlmutter; S D Levin; M W Appleby; S J Anderson; J Alberola-Ila
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

2.  Brief report: a point mutation in the SH2 domain of Bruton's tyrosine kinase in atypical X-linked agammaglobulinemia.

Authors:  D C Saffran; O Parolini; M E Fitch-Hilgenberg; D J Rawlings; D E Afar; O N Witte; M E Conley
Journal:  N Engl J Med       Date:  1994-05-26       Impact factor: 91.245

3.  Mutation analysis of the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia: identification of a mutation which affects the same codon as is altered in immunodeficient xid mice.

Authors:  M de Weers; R G Mensink; M E Kraakman; R K Schuurman; R W Hendriks
Journal:  Hum Mol Genet       Date:  1994-01       Impact factor: 6.150

Review 4.  The PH domain: a common piece in the structural patchwork of signalling proteins.

Authors:  A Musacchio; T Gibson; P Rice; J Thompson; M Saraste
Journal:  Trends Biochem Sci       Date:  1993-09       Impact factor: 13.807

5.  Atypical X-linked agammaglobulinemia.

Authors:  S J Kornfeld; R A Good; G W Litman
Journal:  N Engl J Med       Date:  1994-10-06       Impact factor: 91.245

6.  Binding of Bruton's tyrosine kinase to Fyn, Lyn, or Hck through a Src homology 3 domain-mediated interaction.

Authors:  G Cheng; Z S Ye; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

7.  Genomic organization and structure of Bruton agammaglobulinemia tyrosine kinase: localization of mutations associated with varied clinical presentations and course in X chromosome-linked agammaglobulinemia.

Authors:  Y Ohta; R N Haire; R T Litman; S M Fu; R P Nelson; J Kratz; S J Kornfeld; M de la Morena; R A Good; G W Litman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

8.  The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases.

Authors:  D Vetrie; I Vorechovský; P Sideras; J Holland; A Davies; F Flinter; L Hammarström; C Kinnon; R Levinsky; M Bobrow
Journal:  Nature       Date:  1993-01-21       Impact factor: 49.962

Review 9.  Heterogeneity in the severity of cystic fibrosis and the role of CFTR gene mutations.

Authors:  M Dean; G Santis
Journal:  Hum Genet       Date:  1994-04       Impact factor: 4.132

10.  Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia.

Authors:  S Tsukada; D C Saffran; D J Rawlings; O Parolini; R C Allen; I Klisak; R S Sparkes; H Kubagawa; T Mohandas; S Quan
Journal:  Cell       Date:  1993-01-29       Impact factor: 41.582

View more
  23 in total

Review 1.  Early B cell defects.

Authors:  H B Gaspar; M E Conley
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

Review 2.  X-linked agammaglobulinemia.

Authors:  M E Conley; J Rohrer; Y Minegishi
Journal:  Clin Rev Allergy Immunol       Date:  2000-10       Impact factor: 8.667

3.  A minimally hypomorphic mutation in Btk resulting in reduced B cell numbers but no clinical disease.

Authors:  M E Conley; D M Farmer; A K Dobbs; V Howard; Y Aiba; S A Shurtleff; T Kurosaki
Journal:  Clin Exp Immunol       Date:  2008-01-28       Impact factor: 4.330

Review 4.  Primary antibody deficiencies.

Authors:  Anne Durandy; Sven Kracker; Alain Fischer
Journal:  Nat Rev Immunol       Date:  2013-06-14       Impact factor: 53.106

5.  Phosphoinositide 3-kinase and Bruton's tyrosine kinase regulate overlapping sets of genes in B lymphocytes.

Authors:  David A Fruman; Gregory Z Ferl; Sam S An; Amber C Donahue; Anne B Satterthwaite; Owen N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

6.  Three brothers of X-linked agammaglobulinemia: the relation between phenotype and neutropenia.

Authors:  Chihiro Kawakami; Akiko Inoue; Maki Koh; Kimitaka Takitani; Hirokazu Kanegane; Toshio Miyawaki; Hiroshi Tamai
Journal:  Int J Hematol       Date:  2009-06-17       Impact factor: 2.490

7.  XLA patients with BTK splice-site mutations produce low levels of wild-type BTK transcripts.

Authors:  Jeroen G Noordzij; Sandra de Bruin-Versteeg; Nico G Hartwig; Corry M R Weemaes; Egbert J A Gerritsen; Eva Bernatowska; Stefaan van Lierde; Ronald de Groot; Jacques J M van Dongen
Journal:  J Clin Immunol       Date:  2002-09       Impact factor: 8.317

8.  Unimpaired activation of c-Jun NH2-terminal kinase (JNK) 1 upon CD40 stimulation in B cells of patients with X-linked agammaglobulinemia.

Authors:  Cornelia Brunner; Hans Wolfgang Kreth; Hans D Ochs; Volker Schuster
Journal:  J Clin Immunol       Date:  2002-07       Impact factor: 8.317

Review 9.  Role of the BCR complex in B cell development, activation, and leukemic transformation.

Authors:  Susan R Rheingold; Valerie I Brown; Junjie Fang; Jenny M Kim; Stephan A Grupp
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

10.  Analysis of clinical presentations of Bruton disease: a review of 20 years of accumulated data from pediatric patients at Severance Hospital.

Authors:  Jin-Kyong Chun; Taek Jin Lee; Jae Woo Song; John A Linton; Dong Soo Kim
Journal:  Yonsei Med J       Date:  2008-02-29       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.